Ochratoxin A-induced DNA damage triggers G2 phase arrest via hMLH1-p53-p21 signaling pathway in human gastric epithelium immortalized cells in vitro

Toxicol Lett. 2024 Oct:400:42-48. doi: 10.1016/j.toxlet.2024.08.005. Epub 2024 Aug 6.

Abstract

Ochratoxin A (OTA), as one of the most important and harmful mycotoxins, is classed as possible human carcinogen (group 2B). As we all know, DNA damage may cause genomic instability, cell cycle disorder, activation of DNA damage pathway, and stimulation of DNA repair system. To explore the roles of DNA damage repair protein (hMLH1) on OTA-induced G2 arrest, the DNA damage, chromosome aberration, cell cycle distribution and p53-p21 signaling pathway were evaluatd after different time OTA exposure (6, 12, 24, 48 h) in immortalized human gastric epithelial cells (GES-1). Our results demonstrated that OTA exposure could trigger genomic instability, DNA damage and G2 phase arrest of GES-1 cells. At the same time, OTA treatment could increase the expression of hMLH1, and induce phosphorylation of the p53 protein, as well as p21, in response to DNA damage. Finally, inhibition of hMLH1 by siRNA effectively prevented the activation of p53-p21 signaling pathway and rescued the G2 arrest elicited by OTA. This study demonstrated that hMLH1-p53-p21 signaling pathway played an important role in DNA damage and G2 cell cycle arrest the mediated by OTA in GES-1 cells.

Keywords: G(2) phase arrest; HMLH1 signaling pathway; Ochratoxin A; P53-p21; Signaling pathway.

MeSH terms

  • Cell Line
  • Cyclin-Dependent Kinase Inhibitor p21* / genetics
  • Cyclin-Dependent Kinase Inhibitor p21* / metabolism
  • DNA Damage*
  • Epithelial Cells / drug effects
  • Epithelial Cells / metabolism
  • G2 Phase Cell Cycle Checkpoints* / drug effects
  • Gastric Mucosa* / drug effects
  • Gastric Mucosa* / metabolism
  • Gastric Mucosa* / pathology
  • Genomic Instability / drug effects
  • Humans
  • MutL Protein Homolog 1* / genetics
  • MutL Protein Homolog 1* / metabolism
  • Ochratoxins* / toxicity
  • Phosphorylation
  • Signal Transduction* / drug effects
  • Tumor Suppressor Protein p53* / genetics
  • Tumor Suppressor Protein p53* / metabolism

Substances

  • Ochratoxins
  • ochratoxin A
  • MutL Protein Homolog 1
  • MLH1 protein, human
  • Cyclin-Dependent Kinase Inhibitor p21
  • Tumor Suppressor Protein p53
  • CDKN1A protein, human
  • TP53 protein, human